Alpheus Medical Starts Phase 2b Trial in Glioblastoma
CHANHASSEN, Minnesota, April 9, 2026 Alpheus Medical, Inc. has announced the initiation of its Phase 2b randomized clinical trial...
oncology innovation
Advertisement
Oricell Therapeutics Secures $110M for CAR-T Expansion
SHANGHAI, China, April 10, 2026 Oricell Therapeutics Holdings Limited has successfully closed a $110 million pre-IPO financing round, marking...
Oncolytics Advances Pelareorep Toward Anal Cancer Approval
San Diego, California, USA, April 6, 2026 FDA Engagement Signals Registrational Pathway Progress In a key development for oncolytic...
Cardinal Health Expands Ac-225 Supply for Cancer Therapies
Dublin, Ohio, USA – April 1, 2026 In a significant advancement for the rapidly evolving field of targeted cancer...
OS Therapies Advances OST-HER2 Toward FDA Approval
NEW YORK, March 31, 2026 — OS Therapies, Inc a clinical-stage oncology company specializing in listeria-based cancer immunotherapies, has...
Advertisements
TriSalus Advances Tumor Drug Delivery With PEDD Tech
DENVER, USA – March 18, 2026 TriSalus Life Sciences has announced new preclinical findings demonstrating that its Pressure-Enabled Drug...
Voro Therapeutics Partners with Daiichi Sankyo on ADCs
SAN DIEGO, CA, March 17, 2026 Voro Therapeutics has announced a research collaboration with Daiichi Sankyo to advance its...
Vergent Begins Phase 3 Trial for Lung Imaging Drug
MINNEAPOLIS, Minn., March 17, 2026 Vergent Bioscience has announced the initiation of its Phase 3 VISUALIZE 2 pivotal clinical...
Hyderabad Oncology MoU Advances Precision Cancer Research
HYDERABAD, India, Feb. 16, 2026 — The University of Hyderabad and MNJ Institute of Oncology & Regional Cancer Centre...
Parabilis Raises $305M to Advance First-in-Class Cancer Therapies
Cambridge, Massachusetts — January 8, 2026 — Parabilis Medicines announced the successful close of an oversubscribed $305 million Series...
Advertisement
